The trajectory of Sildenafil presents a complex case for observers in the pharmaceutical sector. While initially a blockbuster success, creating vast sums, the exclusivity expiration and the subsequent entry of generic competitors have considerably changed revenue. This presents questions about the future viability of similar drug developments a… Read More